Norman Schwartz Announces Bio-Rad’s Q3 Sales of $649.7 Million with 3.4% Currency-Neutral Growth, Driven by Clinical Diagnostics

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products,  announced financial r...

October 31, 2024 | Thursday | Company results
Kate Shaw’s Innovative Trials Recognized as UK’s Second Fastest-Growing Woman-Powered Company in Clinical Research

  Innovative Trials is the second fastest-growing, woman-powered UK company in the clinical research sector and in the top 200 overall, according to ...

October 28, 2024 | Monday | News
Avantor CEO Michael Stubblefield Delivers “Just Another” Stellar Q3, Raises 2024 Free Cash Flow Guidance Again

Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% Net income of $57.8 million; Adjusted EBITDA of $302.5 milli...

October 28, 2024 | Monday | Company results
Thermo Fisher CEO Marc N. Casper Highlights Strong Q3 2024 Results with $10.6 Billion Revenue and Breakthrough Innovations

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, reported its financial results for the third quarter ended September 28, ...

October 24, 2024 | Thursday | Company results
Roche CEO Thomas Schinecker Highlights Strong Q3 Growth Fueled by Innovative Medicines and Diagnostic Solutions

Roche’s latest financial report highlights its robust performance, driven by innovation in its pharmaceutical and diagnostics divisions, while navi...

October 23, 2024 | Wednesday | Company results
Catalent CEO John Chiminski Issues Open Letter Addressing Novo Holdings’ Acquisition and Reaffirms Commitment to Customers

Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, issued the following open lette...

October 22, 2024 | Tuesday | News
Telix CEO Dr. Christian Behrenbruch Highlights Strong Progress in Radiopharmaceutical Leadership

Telix Pharmaceuticals provides an update on its revenue and operational performance for the quarter ended 30 September 2024 (Q3 2024). Revenue update, f...

October 17, 2024 | Thursday | Company results
Sherry Shao, Rotating CEO of GenScript, Celebrates MSCI's A Rating for Improved ESG Performance

"The A rating from MSCI is a significant recognition of our improvement in ESG performance," said Sherry Shao, Rotating CEO of GenScript. "We believe that ...

October 14, 2024 | Monday | News
Americans Victor Ambros and Gary Ruvkun Win Nobel Prize in Medicine for Landmark Discovery of microRNA

The Nobel Prize in Physiology or Medicine has been awarded to American researchers Victor Ambros and Gary Ruvkun for their pioneering discovery of microR...

October 07, 2024 | Monday | News
Sygnature Discovery Appoints Amira Modi as New Chief Operating Officer and Board Member

World-leading contract research organization (CRO) Sygnature Discovery is delighted to announce the appointment of Amira Modi as its new Chief Operating ...

October 04, 2024 | Friday | News
Transforming Vision: Jacqueline Henderson on Johnson & Johnson's Groundbreaking IOL Innovations

As President of EMEA at Vision Johnson & Johnson, Jacqueline Henderson is at the forefront of innovation in ophthalmology, overseeing the development...

October 01, 2024 | Tuesday | Interview
Eli Lilly CEO David Ricks Announces Major Expansion of India Research Hub, Poised to Transform Global Drug Innovation

Eli Lilly and Company (NYSE: LLY), a global leader in biopharmaceuticals, has announced plans to expand its research and development (R&D) center in ...

September 24, 2024 | Tuesday | News
The Future of Synthetic Biology: Streamlining Innovation With New Technology

Clore and Ottensmann explain:   Synthetic biology is revolutionizing medical treatments for a wide range of diseases. It’s what made it possib...

September 18, 2024 | Wednesday | Expert Opinion
Enzene Biosciences Appoints Norm Stoffregen as SVP and Head of New $50 Million Biologics Manufacturing Facility in New Jersey

Enzene Biosciences, a fully integrated CDMO with services spanning discovery, development and commercial supply, today announced the appointment of Norm St...

September 04, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close